Related Experiment Video
Updated: May 8, 2026

MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus
Manish Bhomia1, Anuj Sharma, Manoshi Gayen
1Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, Rajasthan 333031, India.
Abstract:
Venezuelan equine encephalitis virus is a member of the alphavirus family and genus togaviridae. VEEV is highly infectious in aerosol form and has been weaponized in the past making it a potential biothreat agent. At present, there are no FDA approved antiviral treatments or vaccines for VEEV. Artificial microRNAs are small molecules which are expressed through endogenous microRNA machinery by RNA polymerase II. These artificial microRNAs effectively inhibit gene expression and are non-toxic to the host cell. VEEV RNA dependent RNA polymerase (RdRp) is central to VEEV replication. Therefore, we hypothesize that targeted inhibition of VEEV RdRp using artificial microRNAs may efficiently inhibit VEEV replication. Five artificial microRNAs were tested in vitro in BHK cells. Three of these artificial miRNAs showed significant inhibition of VEEV replication. Further, these microRNAs were cloned into the expression vector in combination to see the synergistic effect on VEEV replication. Combination of more than one miRNA did not result in significant inhibition of virus replication. In conclusion, we have shown that RNAi through artificial microRNAs effectively inhibits VEEV replication and is significantly less toxic in comparison to siRNAs.
Related Concept Videos
MicroRNAs
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

